Clinical Trial Update: Dose-Finding Safety Study of BIIB014 in Combination With Levodopa in Moderate to Late Stage Parkinson's Disease [Phase 2]

View source ↗

Summary

This completed Phase 2 dose-finding safety study evaluated BIIB014 in combination with levodopa in patients with moderate to late-stage Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• BIIB014
• levodopa (levodopa)

Snippet

Sponsor: Biogen | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED